AnaptysBio Inc buy Wells Fargo & Company
Start price
12.12.24
/
50%
€14.40
Target price
12.12.25
€38.17
Performance (%)
165.28%
End price
13.12.25
-
Summary
This prediction is currently being closed. The BUY prediction by Wells_Fargo___Compan for AnaptysBio Inc has seen massive gains of 165.28%. Wells_Fargo___Compan has a follow-up prediction for AnaptysBio Inc where he still thinks AnaptysBio Inc is a Buy. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| AnaptysBio Inc | 0.529% | 0.529% | 158.503% |
| iShares Core DAX® | 0.734% | 1.458% | 17.980% |
| iShares Nasdaq 100 | -2.686% | -0.146% | 3.810% |
| iShares Nikkei 225® | -2.261% | -2.729% | 11.679% |
| iShares S&P 500 | -1.346% | 0.467% | 1.970% |
Comments by Wells_Fargo___Compan for this prediction
In the thread AnaptysBio Inc diskutieren
AnaptysBio, Inc. (NASDAQ: ANAB) had its price target lowered by analysts at Wells Fargo & Company from $56.00 to $40.00. They now have an "overweight" rating on the stock.
Ratings data for ANAB provided by MarketBeat
In the thread Trading AnaptysBio Inc
Die von Wells_Fargo___Compan gewählte maximale Laufzeit wurde überschritten